Description
The Global Client Partner is a senior client leadership role responsible for helping Asia-based Emerging Biopharma companies, particularly China-headquartered innovators, successfully navigate the journey from asset development to commercialization and lifecycle growth.
Acting as a trusted advisor to executive leadership teams, the Global Client Partner builds long-term strategic relationships while mobilizing IQVIA's full portfolio of capabilities to help clients make critical commercial, evidence, market access, medical, and launch decisions.
This role partners closely with CEOs, founders, Chief Commercial Officers, Heads of International Business, Commercial Strategy, Market Access, Medical Affairs, and other senior leaders to shape commercialization strategies, accelerate launch readiness, and identify opportunities for growth across the asset lifecycle.
Key Responsibilities
- Build executive-level relationships with CEOs, founders, Chief Commercial Officers, Heads of International Business, commercial, market access, medical affairs, and business development leaders across assigned Asia-based Emerging Biopharma accounts.
- Serve as a trusted advisor, bringing global commercialization perspective, industry insight, and thought leadership to help clients make critical asset, launch, licensing, partnership, and growth decisions.
- Lead strategic engagement around priority assets by understanding development milestones, competitive dynamics, market opportunities, launch risks, evidence needs, and global expansion objectives.
- Develop asset-based account strategies that align IQVIA capabilities with client priorities from late-stage development through launch, international expansion, and lifecycle growth.
- Advise clients on commercialization strategy, launch readiness, market access, evidence generation, operating model design, and market entry priorities across the US, Europe, China, Japan, and other priority geographies.
- Connect IQVIA Consulting, Analytics, Real World Evidence, Medical Affairs, Market Access, Technology, RDS, and Commercial Execution into integrated molecule-to-market solutions.
- Leverage proximity to Asia and China-based executive decision-makers to drive global business growth, open new business streams, and increase IQVIA's footprint across assigned accounts.
- Shape and sponsor complex, cross-functional opportunities by mobilizing senior IQVIA leaders and subject matter experts across Asia, the US, Europe, and global delivery teams to create differentiated client value.
- Lead internal account planning and governance across global and regional teams to ensure coordinated engagement, clear priorities, consistent client messaging, and strong handoffs across markets.
- Represent the client's voice within IQVIA, translating Asia-based client ambitions, asset priorities, and partnership expectations into practical action and long-term global partnership value.
Our Ideal Candidate
- 15+ years of experience in life sciences, commercialization, management consulting, business development, or other senior client-facing leadership roles, with preferred global experience working with Asia-based or China-headquartered biopharma companies.
- Deep understanding of drug commercialization, launch excellence, market access, evidence generation, and lifecycle management across the pharmaceutical industry, including the needs of companies expanding beyond their home market.
- Demonstrated success advising Emerging Biopharma companies and supporting products through late-stage development, launch preparation, international expansion, commercialization, or growth phases.
- Proven ability to build trusted relationships with CEOs, founders, C-suite leaders, investors, international business leaders, and senior commercial executives.
- Strong consultative selling capabilities with a track record of identifying, shaping, and closing complex multi-service opportunities across functions and geographies.
- Experience managing both near-term opportunities and multi-year strategic partnerships while consistently delivering growth objectives.